JomCare Study - A Harm Reduction Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity of Connecticut
About this trial
Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥18 years;
Cisgender man;
HIV-negative or HIV status unknown;
Having engaged in "chemsex" in the past 12 months (defined as using CAD, including crystal methamphetamine, mephedrone, GBL/GHB, and/or ecstasy/MDMA)
Disqualifiers
Unable to provide informed consent
Enrolled in drug rehabilitation, substance use treatment, and narcotics or other behavioral intervention-based treatment
Unable to read and understand English or Bahasa Malaysia
Trial design
Design model
Sequential
Treatments tested in this trial
JomCare is a smartphone-based just-in-time adaptive intervention (JITAI) for chemsex-related harm reduction.
BehavioralJomCare is a smartphone-based just-in-time adaptive intervention (JITAI) that uses an EMA-based machine learning (ML) algorithm to anticipate chemsex risk and deliver appropriate chemsex-related harm reduction and HIV prevention services when the risk is detected.
Treatment groups
482 Participants
are divided into 5 treatment groupsGroup A: Information-based engagement promptsExperimental treatment 1 intervention
Group B: Motivation-based engagement promptsExperimental treatment 1 intervention
Group C: Behavioral skills-based engagement promptsExperimental treatment 1 intervention
Group D: Generic engagement promptsActive comparator 1 intervention
Group E: No engagement promptNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Number of participants engaged in chemsex risk behavior
Use of chemsex-associated drugs, engagement in condomless anal sex, CAD overdose since the last EMA
Time frame
Up to 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Connecticut
Lead sponsor
University of Malaya
Collaborator
Yale University
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
University of Michigan
Collaborator
University of Texas at Tyler
Collaborator
Ohio State University
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: